Objective: The incidence of osteoporosis complicated by vertebral compression fractures (OVCF) has been increasing annually, and percutaneous vertebroplasty (PVP) is the main surgical approach for it. It was to evaluate the use of a small needle knife (SNF) in conjunction with PVP to assess changes in inflammatory response, Th17 cell function, and magnetic resonance imaging (MRI) parameters in OVCF patients.
Methods: A retrospective analysis was conducted using the clinical data of 138 patients with OVCF, who were categorized into PVP group (n = 65) and PVP + SNF group (n = 73). MRI was employed to evaluate changes in lumbar spine anatomy and paraspinal muscle parameters. The postoperative thoracic and intercostal pain and joint function recovery were assessed. Blood samples were collected to measure inflammatory factors, Th17 cell proportions, and related cytokine levels.
Results: PVP + SNF group showed decreased visual analogue scale (VAS) scores at 3 days, 7 days, and 1 month postoperatively versus PVP group (P < 0.05). MRI examination indicated significant improvements in anterior vertebral height, posterior vertebra height, multifidus cross-sectional area, and erector spinae cross-sectional area, along with a decrease in steatosis proportion in the PVP + SNF group (P < 0.05).
Conclusion: SNF in combination with PVP reduced postoperative pain and improved lumbar spine function in OVCF patients. Furthermore, it can lower inflammatory responses by enhancing Th17 cell function. MRI examinations can serve as valuable tools for predicting and assessing postoperative outcomes in OVCF patients.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.exger.2025.112719 | DOI Listing |
Gut
March 2025
Department of Gastroenterology, Shanghai Tenth People's Hospital, Shanghai, China
Background: GPR171 suppresses T cell immune responses involved in antitumour immunity, while its role in inflammatory bowel disease (IBD) pathogenesis remains unclear.
Objective: We aimed to investigate the role of GPR171 in modulating CD4 T cell effector functions in IBD and evaluate its therapeutic potential.
Design: We analysed GPR171 expression in colon biopsies and peripheral blood samples from patients with IBD and assessed the impact of GPR171 on CD4 T cell differentiation through administration of its endogenous ligand (BigLEN).
J Immunol
February 2025
La Jolla Institute for Immunology, La Jolla, CA, United States.
A fundamental dichotomy in lymphocytes separates adaptive T and B lymphocytes, with clonally expressed antigen receptors, from innate lymphocytes, which carry out more rapid responses. Some T cell populations, however, are intermediates between these 2 poles, with the capacity to respond rapidly through T cell receptor activation or by cytokine stimulation. Here, using publicly available datasets, we constructed linear mixed models that not only define a gradient of innate gene expression in common for mouse innate-like T cells, but also are applicable to other mouse T lymphoid populations.
View Article and Find Full Text PDFLiver fibrosis is a global health problem. IL-17A has proven profibrogenic properties in liver disease making it an interesting therapeutic target. IL-17A is regulated by RORγt and produced by Th17 CD4+ and γδ-T cells.
View Article and Find Full Text PDFJ Immunol
February 2025
Genentech, Inc, South San Francisco, CA, United States.
A gene encoding the transcription factor RTF1 has been associated with an increased risk of ulcerative colitis (UC). In this study, we investigated its function in modulating T cells expressing interleukin-17A (Th17 cells), a cardinal cell type promoting intestinal inflammation. Our results indicate that Rtf1 deficiency disrupts the differentiation of Th17 cells, while leaving regulatory T cells (Treg) unaffected.
View Article and Find Full Text PDFClin Rev Allergy Immunol
March 2025
School of Chinese Medicine, Hong Kong Baptist University, Hong Kong, China.
Uveitis involves a complex interplay of immune cell infiltration and cytokine imbalances, with Th17 cells playing a central role in this process. Th17 cells contribute to disease pathogenesis by promoting inflammation, recruiting additional immune cells, and directly damaging retinal tissues. This review discusses the current knowledge on therapeutic strategies targeting Th17-related cytokines, including cytokine blockade, small molecule inhibitors, and immunomodulatory approaches.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!